BCEL
Atreca Inc
Price:  
0.15 
USD
Volume:  
655,684.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

Atreca Intrinsic Value

-13,797.93 %
Upside

What is the intrinsic value of Atreca?

As of 2026-03-21, the Intrinsic Value of Atreca Inc (BCEL) is -20.55 USD. This Atreca valuation is based on the model Peter Lynch Fair Value. With the current market price of 0.15 USD, the upside of Atreca Inc is -13,797.93%.

Is Atreca undervalued or overvalued?

Based on its market price of 0.15 USD and our intrinsic valuation, Atreca Inc (BCEL) is overvalued by 13,797.93%.

Note: result may not be accurate due to the invalid valuation result of Peter Lynch's fair value model.

0.15 USD
Stock Price
-20.55 USD
Intrinsic Value
Intrinsic Value Details

Atreca Intrinsic Value - Valuation Summary

Range Selected Upside
a
Fair Value -20.55 - -20.55 -20.55 -13,797.93%
P/E (75.28) - (87.28) (83.01) -55439.7%
DDM - Stable (57.63) - (965.65) (511.64) -341193.7%
DDM - Multi (33.53) - (438.86) (62.41) -41709.4%

Atreca Intrinsic Value - Key Valuation Metrics

Market Cap (mil) 3.57
Beta 4.37
Outstanding shares (mil) 23.79
Enterprise Value (mil) -9.93
Market risk premium 4.60%
Cost of Equity 6.69%
Cost of Debt 5.00%
WACC 5.18%